44 results
8-K
EX-99.2
KNSA
Kiniksa Pharmaceuticals Ltd - Ordinary Shares
2 Apr 24
Kiniksa Pharmaceuticals Announces Development Indication for Abiprubart
7:32am
trial priority, operating plan, business development strategy or funding requirements; raw materials, important ancillary product and drug substance
8-K
EX-99.2
KNSA
Kiniksa Pharmaceuticals Ltd - Ordinary Shares
4 Jan 24
Kiniksa Pharmaceuticals Provides Corporate Update
7:37am
priority, operating plan, business developme nt strategy or funding requirements; raw materials, important ancillary product and drug substance
8-K
EX-99.1
59tus5gs6y
1 Nov 22
Kiniksa Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
8:06am
8-K
EX-99.1
aewztxr 5n
3 Aug 22
Kiniksa Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update
7:35am
8-K
EX-99.1
35ce8ab6 z918
3 May 22
Kiniksa Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update
9:09am
8-K
EX-99.2
o77ug
22 Feb 22
Kiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Corporate Update
8:06am
8-K
EX-99.1
xl6wrn 5yq
22 Feb 22
Kiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Corporate Update
8:06am
8-K
EX-99.1
l8467ywi7wp0m1wsp
10 Jan 22
Kiniksa Provides Corporate Update and Outlines Anticipated 2022 Milestones
8:56am